To your point about sitting on genetics, Don, Newflora, as I understand it, evaluates what they think will be marketable and do well and maintain the reputation of their offerings, and then decides what makes it to the American market. Lemon Fizz (Kordes 2001), for instance, they offered, while the Europeans rejected it. After their experience with it, Newflora sent it back to Germany where it won an ADR in 2015, and will probably make it to market in a year or two.
Markets differ, apparently, either due to taste or different strains of disease. I heard, for instance, that KO never made much of a splash in Europe and was considered over-rated. Whether that's a function of tastes, disease, or marketing, I have no idea.
There is a risk in mediocre roses getting over-promoted and hurting the reputation.
I had a quick communication with Chris Pellett at Newflora about the Firebird rose I had mentioned in another post. Of this rose, he said, "...we have had it in trial since 2010. Yes good on disease and the color is really quite unusual. Fairly compact plant and maybe more so as an own root plant. Foliage is quite nice - that typical glossy, bright green foliage we see with the Kordes breeding. We have introduced this variety and it should be available in the next year from rose producers."
Last edited by philip_la
on Wed Apr 05, 2017 3:53 pm, edited 1 time in total.
[size=small][color=#669966]Zone 8 / Sunset Zn 30 (Austin, TX -- formerly New Orleans, LA)[/color][/size]